Results
|
54961.
|
|
|
54962.
|
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial. [electronic resource] by
- Bazinet, Michel
- Pântea, Victor
- Cebotarescu, Valentin
- Cojuhari, Lilia
- Jimbei, Pavlina
- Albrecht, Jeffrey
- Schmid, Peter
- Le Gal, Frédéric
- Gordien, Emmanuel
- Krawczyk, Adalbert
- Mijočević, Hrvoje
- Karimzadeh, Hadi
- Roggendorf, Michael
- Vaillant, Andrew
Producer: 20180813
In:
The lancet. Gastroenterology & hepatology vol. 2
Availability: No items available.
|
|
54963.
|
|
|
54964.
|
|
|
54965.
|
|
|
54966.
|
|
|
54967.
|
|
|
54968.
|
|
|
54969.
|
|
|
54970.
|
A non-interventional phase IV Belgian survey to assess the antiviral effectiveness of pegylated interferon-alpha-2b and ribavirin treatment according to the stage of liver fibrosis in previously untreated patients with genotype 1/4/5/6 chronic hepatitis C (PRACTICE). [electronic resource] by
- Bourgeois, S
- Deltenre, P
- Delwaide, J
- Henrion, J
- Adler, M
- Langlet, Ph
- Mulkay, J-P
- Nevens, F
- Brixko, C
- Moreno, C
Producer: 20150320
In:
Acta gastro-enterologica Belgica vol. 77
Availability: No items available.
|
|
54971.
|
|
|
54972.
|
|
|
54973.
|
|
|
54974.
|
|
|
54975.
|
|
|
54976.
|
|
|
54977.
|
|
|
54978.
|
|
|
54979.
|
|
|
54980.
|
|